Last updated on June 2019

A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors (Study #1)


Brief description of study

This Phase III, double blind, placebo and active comparator controlled, multicenter study will investigate the efficacy and safety of etrolizumab in induction of remission in participants with moderately to severely active UC who are naIve to TNF inhibitors and refractory to or intolerant of prior immunosuppressant and/or corticosteroid treatment.

Clinical Study Identifier: NCT02163759

Find a site near you

Start Over

Preferred Research Partners, Inc.

Little Rock, AR United States
  Connect »

Carle Foundation

Urbana, IL United States
  Connect »

University of Louisville

Louisville, KY United States
  Connect »

Gastroenterology Associates, LLC

Baton Rouge, LA United States
  Connect »

OU Health Science Center GI

Oklahoma City, OK United States
  Connect »

ClinSearch, LLC

Chattanooga, TN United States
  Connect »

Hospital General de Agudos Dr. Cosme Argerich

Ciudad Autonoma Buenos Aires, Argentina
  Connect »

Instituto CAICI

Rosario, Argentina
  Connect »

Emeritus Research

Malvern East, Australia
  Connect »

MC Medica Plus

Veliko Tarnovo, Bulgaria
  Connect »

O Innomedica

Tallinn, Estonia
  Connect »

Wellness Clinical Research Center

San Antonio, TX United States
  Connect »

UC Health, LLC.

Cincinnati, OH United States
  Connect »

Mater Hospital Brisbane

South Brisbane, Australia
  Connect »

Tuen Mun Hospital

Hong Kong, Hong Kong
  Connect »

Center For Digestive Health

Orlando, FL United States
  Connect »

H pital Beaujon

Clichy cedex, France
  Connect »

Houma Digestive Health

Houma, LA United States
  Connect »

Clinical Research of Rock Hill

Rock Hill, SC United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.